ProVise Management Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.5M Buy
136,467
+3,644
+3% +$441K 1.3% 25
2025
Q1
$14.8M Buy
132,823
+3,464
+3% +$386K 1.26% 22
2024
Q4
$12.6M Sell
129,359
-2,531
-2% -$246K 1.08% 30
2024
Q3
$15.2M Buy
131,890
+3,337
+3% +$384K 1.2% 23
2024
Q2
$13.7M Buy
128,553
+1,163
+0.9% +$124K 1.16% 27
2024
Q1
$12.3M Buy
127,390
+3,074
+2% +$297K 1.07% 28
2023
Q4
$12.6M Buy
124,316
+4,123
+3% +$416K 1.06% 25
2023
Q3
$12.2M Buy
120,193
+3,651
+3% +$372K 1.14% 24
2023
Q2
$11.8M Buy
116,542
+2,933
+3% +$296K 1.07% 27
2023
Q1
$10.5M Buy
113,609
+567
+0.5% +$52.2K 1% 30
2022
Q4
$10.3M Buy
113,042
+7,756
+7% +$704K 1.04% 27
2022
Q3
$8M Buy
105,286
+8,377
+9% +$637K 0.89% 36
2022
Q2
$8.19M Buy
96,909
+7,369
+8% +$623K 0.87% 37
2022
Q1
$7.86M Buy
89,540
+1,693
+2% +$149K 0.74% 39
2021
Q4
$7.68M Buy
87,847
+3,664
+4% +$320K 0.7% 41
2021
Q3
$6.88M Buy
84,183
+3,802
+5% +$311K 0.68% 43
2021
Q2
$7.33M Sell
80,381
-528
-0.7% -$48.2K 0.75% 34
2021
Q1
$6.92M Buy
80,909
+174
+0.2% +$14.9K 0.75% 35
2020
Q4
$7.62M Buy
80,735
+1,155
+1% +$109K 0.88% 28
2020
Q3
$6.92M Sell
79,580
-385
-0.5% -$33.5K 0.93% 27
2020
Q2
$6.98M Sell
79,965
-1,908
-2% -$167K 1% 25
2020
Q1
$6.75M Sell
81,873
-3,138
-4% -$259K 1.13% 22
2019
Q4
$8.05M Sell
85,011
-325
-0.4% -$30.8K 0.99% 31
2019
Q3
$7.42M Sell
85,336
-655
-0.8% -$56.9K 0.98% 28
2019
Q2
$7.85M Sell
85,991
-10,484
-11% -$957K 1.05% 23
2019
Q1
$8.31M Sell
96,475
-2,375
-2% -$205K 1.17% 21
2018
Q4
$7.6M Sell
98,850
-4,520
-4% -$348K 1.2% 19
2018
Q3
$7.98M Sell
103,370
-492
-0.5% -$38K 1.05% 23
2018
Q2
$10.8K Sell
103,862
-789
-0.8% -$82 0.81% 40
2018
Q1
$7.58M Sell
104,651
-1,919
-2% -$139K 1.12% 21
2017
Q4
$8.02M Sell
106,570
-313
-0.3% -$23.5K 1.15% 22
2017
Q3
$8.22M Buy
106,883
+11,977
+13% +$921K 1.19% 20
2017
Q2
$7.1M Buy
94,906
+10,298
+12% +$770K 1.08% 22
2017
Q1
$5.63M Buy
84,608
+10,970
+15% +$730K 0.9% 29
2016
Q4
$4.81M Sell
73,638
-10,914
-13% -$712K 0.82% 32
2016
Q3
$5.98M Buy
84,552
+4,213
+5% +$298K 1.04% 18
2016
Q2
$5.94M Buy
80,339
+6,372
+9% +$471K 1.09% 18
2016
Q1
$4.8M Buy
73,967
+16,862
+30% +$1.09M 0.99% 21
2015
Q4
$4.4M Buy
57,105
+4,721
+9% +$364K 0.92% 22
2015
Q3
$4.32M Buy
52,384
+737
+1% +$60.7K 1% 21
2015
Q2
$4.55M Buy
51,647
+1,022
+2% +$90.1K 0.97% 23
2015
Q1
$4.47M Buy
50,625
+418
+0.8% +$36.9K 0.95% 22
2014
Q4
$4.17M Buy
50,207
+7,885
+19% +$655K 0.89% 26
2014
Q3
$3.57M Buy
42,322
+1,959
+5% +$165K 0.78% 31
2014
Q2
$3.27M Buy
40,363
+1,131
+3% +$91.7K 0.71% 34
2014
Q1
$2.99M Buy
39,232
+1,534
+4% +$117K 0.72% 34
2013
Q4
$2.72M Buy
37,698
+1,963
+5% +$141K 0.7% 34
2013
Q3
$2.46M Buy
35,735
+2,493
+7% +$171K 0.7% 31
2013
Q2
$2.11M Buy
+33,242
New +$2.11M 0.62% 39